脂毒性
安普克
炎症
糖尿病性心肌病
化学
药理学
活性氧
脂质过氧化
一氧化氮
丙二醛
细胞凋亡
一氧化氮合酶
氧化应激
内科学
内分泌学
心肌病
蛋白激酶A
医学
生物化学
激酶
糖尿病
心力衰竭
胰岛素抵抗
作者
Wanqiu Zhang,Jinghua Lu,Yangyang Wang,Pengbo Sun,Tong Gao,Naihan Xu,Yaou Zhang,Weidong Xie
摘要
Diabetic cardiomyopathy (DCM) is a myocardial disease independent of other cardiovascular diseases, such as coronary heart disease, hypertension, etc. Lipotoxicity is closely related to DCM. In this study, we investigated the mechanism of lipid metabolism disturbance in DCM in HL-1 cells. Through bioinformatics and Western blotting analysis, we found that canagliflozin (CAN) significantly inhibited the expression of inflammatory factors cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). Ferroptosis is mediated by lipid peroxidation. We demonstrated the presence of ferroptosis in cardiomyocytes by detecting intracellular Fe2+ content and the levels of reactive oxygen species (ROS), malondialdehyde (MDA), reduced glutathione (GSH), and mitochondrial membrane potential (MMP). CAN could significantly regulate the indicators of ferroptosis. By using specific inhibitors celecoxib (coxib), S-methylisothiourea sulfate (SMT), Ferrostatin-1 (Fer-1), and Compound C, we further found that CAN regulated inflammation and ferroptosis through AMP-activated protein (AMPK), and inflammation interacted with ferroptosis. Our study indicated that CAN attenuated lipotoxicity in cardiomyocytes by regulating inflammation and ferroptosis through activating the AMPK pathway. This study provides a new direction of myocardial lipotoxicity and some new information for the treatment of DCM.
科研通智能强力驱动
Strongly Powered by AbleSci AI